Stable stroke incidence rates but improved case-fatality in Dijon, France, from 1985 to 2004

Stroke. 2006 Jul;37(7):1674-9. doi: 10.1161/01.STR.0000226979.56456.a8. Epub 2006 May 25.

Abstract

Background and purpose: With the progress in stroke prevention, it is important to evaluate the epidemiological trends of strokes over a long period and from a nonselected population-based perspective.

Methods: We estimated changes in incidence, case-fatality rates, severity, risk factors and prestroke use of preventive treatments for first-ever strokes, from a continuous 20-year well-defined population-based registry, from 1985 to 2004.

Results: We recorded 3142 ischemic strokes, 341 primary cerebral hemorrhages and 74 subarachnoid hemorrhages. During the 20-year study, the age at first stroke onset increased by 5 years in men and 8 years in women. Comparing the 1985 to 1989 and the 2000 to 2004 periods, age- and sex-standardized incidences of first-ever strokes were stable except for lacunar strokes whose incidence significantly increased (P=0.01) and for cardioembolic stroke whose incidence significantly decreased (P=0.01). Twenty-eight-day case-fatality rates decreased significantly mainly for lacunar strokes (P=0.05) and for primary cerebral hemorrhages (P=0.03). The proportion of hypercholesterolemia and diabetes significantly increased (P<0.01). In contrast, the proportion of myocardial infarction significantly decreased (P=0.02). Prestroke antiplatelets and anticoagulants treatment significantly increased (P<0.01).

Conclusions: The age- and sex-standardized incidences of first strokes in Dijon have been stable over the past 20 years and were associated with an increase in age at stroke onset, a decrease in case-fatality rates, and an increased use of antiplatelet treatments.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anticoagulants / therapeutic use
  • Atrial Fibrillation / epidemiology
  • Carotid Stenosis / epidemiology
  • Comorbidity
  • Diabetes Mellitus / epidemiology
  • Female
  • France / epidemiology
  • Humans
  • Hypercholesterolemia / epidemiology
  • Hypertension / epidemiology
  • Incidence
  • Ischemic Attack, Transient / epidemiology
  • Male
  • Middle Aged
  • Morbidity / trends
  • Mortality / trends
  • Platelet Aggregation Inhibitors / therapeutic use
  • Registries
  • Risk Factors
  • Smoking / epidemiology
  • Stroke / epidemiology*
  • Stroke / mortality
  • Stroke / prevention & control
  • Vertebrobasilar Insufficiency / epidemiology

Substances

  • Anticoagulants
  • Platelet Aggregation Inhibitors